Aurora Cannabis Inc. is engaged in the production and sale of medical cannabis. The Company is engaged in the business of producing and distributing medical marijuana pursuant to the Access to Cannabis for Medical Purposes Regulations (ACMPR). The Company's product types include Tetrahydrocannabinol (THC), Cannabidiole (CBD), indica, sativa and hybrid. Its product range includes BLACK TUSK 2, CHESTER, KAINE and TOWER. The Company is also focusing on other products, which will be available for sale either as pre-milled buds (Borealis Blends) or as whole buds, including ANDROMEDA 2, HAIDUK, SENTINEL, SNOW DOME, STOKES and WARWICK #2. The THC product is responsible for the felt from cannabis and is connected to the immune system regulating, anti-inflammatory and pain relieving properties of medical marijuana. The CBD product is connected to the anti-inflammatory, pain relieving, anti-nausea, anti-anxiety and muscle relaxing functions of medical marijuana.